|
|
VELCADE® RESOURCE PAGE
VELCADE® (bortezomib) for Injection is an antineoplastic agent available for injection into a vein (intravenously or IV) or under the skin (subcutaneously). VELCADE must not be administered into the spinal fluid (intrathecally). It has been approved by the FDA for the treatment of myeloma. For information about VELCADE, call Millennium at 1-866-VELCADE or the IMF hotline at (800) 452-CURE (800-452-2873).
|
|
|
|
![]()
|
The approval is based on data from a Phase III study demonstrating that subcutaneous administration of bortezomib is equally effective as intravenous bortezomib but is associated with a significant reduction in the frequency and severity of side effects. |
|
|
|
print
back to top